Reanah Ford sought orthodontic treatment through Byte, a clear aligner company, which promised quick results via social media marketing. After several months of use, Ford experienced severe dental damage and financial loss, as Byte abruptly ceased operations and left customers without recourse. Byte had received approval from Australia's Therapeutic Goods Administration (TGA), but the regulatory body does not actively review safety data for 'Class I' medical devices, which are considered low-risk. This lack of oversight allows companies to self-regulate, leading to potential harm. Investigations reveal that over 5,000 adverse events, including injuries and deaths, have been reported for Class I devices since 2012, with Byte being among the most frequently complained about.
Bias read (Progressive): The article highlights systemic failures in medical device regulation by the TGA, emphasizing inadequate oversight and corporate accountability. It critiques the current regulatory framework as overly lenient and exposes risks to consumers due to minimal scrutiny of low-risk devices. The tone is in
